No abstract available
MeSH terms
-
Antiviral Agents* / economics
-
Antiviral Agents* / therapeutic use
-
Betacoronavirus*
-
COVID-19
-
Coronavirus Infections / drug therapy
-
Coronavirus Infections / epidemiology*
-
Coronavirus Infections / prevention & control
-
Coronavirus Infections / transmission
-
Drug Discovery* / economics
-
Financing, Government
-
Humans
-
Pandemics / prevention & control*
-
Pneumonia, Viral / drug therapy
-
Pneumonia, Viral / epidemiology*
-
Pneumonia, Viral / prevention & control
-
Pneumonia, Viral / transmission
-
Population Surveillance
-
SARS-CoV-2
-
Viral Vaccines*
Substances
-
Antiviral Agents
-
Viral Vaccines